Role of osmolality of contrast media in the development of post-ERCP pancreatitis: A metanalysis

Digestive Diseases and Sciences

Volumn 49, Issue 3, 2004, Pages 503-508

  George, Suku ^a   Kulkarni, Arvind A ^a   Stevens, Gary ^a   Forsmark, Chris E ^a   Draganov, Peter ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b Divisions of Gastroenterology   (United States)

Author keywords

Contrast media; ERCP; Osmolality; Pancreatitis

Indexed keywords

CONTRAST MEDIUM; IOHEXOL; IOPAMIDOL; IOXAGLIC ACID; MEGLUMINE DIATRIZOATE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; PANCREAS ENZYME;

ABDOMINAL PAIN; CLINICAL TRIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FISHER EXACT TEST; HUMAN; META ANALYSIS; OSMOLALITY; PANCREATITIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW; SAMPLE SIZE;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CONTRAST MEDIA; HUMANS; IOHEXOL; IOXAGLIC ACID; LOGISTIC MODELS; OSMOLAR CONCENTRATION; PANCREATITIS; RANDOMIZED CONTROLLED TRIALS;

EID: 1842504076     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000020511.98230.20     Document Type: Review

References (31)

1. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, Overby CS, Aas J, Ryan ME, Bochna GS, Shaw MJ, Snady HW, Erickson RV, Moore JP, Roel JP: Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest Endosc 54(4):425-434, 2001
2. Sherman S, Lehman GA: ERCP and endoscopie sphincterotomy induced pancreatitis. Pancreas 6:350-367, 1991
3. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, Lande JD, Pheley AM: Complications of endoscopic biliary sphincterotomy. N Engl J Med 335:909-918, 1996
4. Haber G: Prevention of post-ERCP pancreatitis. Gastrointest Endosc 51(1):1-7, 2000
5. Chen YK, Foliente RL, Santoro MJ, Walter MH, Collen MJ: Complications of endoscopic sphicterotomy: a prospective series with emphasis on increased risk associated with non dilated bile ducts and sphicter of Oddi dysfunction. Am J Gastroenterol 89:327-333, 1994
6. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A: Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48:1-10, 1998
7. Bub H, Burner W, Riemann JF, Stolte M: Morphology of the pancreatic ductal epithelial after traumatization of the papilla of Vater or endoscopic retrograde pancreaticography with various contrast media in cats. Scand J Gastroenterol 18:581-592, 1983
8. Saari A, Kivisaari L, Standertskjold-Nordenstam CG, Brackett K, Schroder T: Experimental pancreatography: A comparison of three contrast media. Scand J Gastroenterol 23(1):53-58, 1988
9. Kimmey M, Al-Kawas F, Carr-Locke D, Edmundowicz SA, Gannan RA, Jamidar PA, Saeed ZA, Stein TN: Technology assessment status evaluation. Radiographic contrast media used in ERCP. Gastrointest Endosc 43:647-651, 1996
10. Osnes M, Skjennald A, Larsen S: A comparison of a new non-ionic (metrizamide) and a dissociable (metroizoate) contrast medium in endoscopic retrograde pancreaticography (ERP). Scand J Gastroenterol 12:821-825, 1977
11. Cunliffe WJ, Cobden I, Lavelle MI, Lendrum R, Tait NP, Venables CW: A randomized prospective study comparing two contrast media in ERCP. Endoscopy (Suppl) 19:201-202, 1987
12. O'Connor HJ, Ellis WR, Manning AP, Lintott DJ, McMahon MJ, Axon AT: Iopamidol as contrast medium in endoscopic retrograde pancreatography: A prospective randomized comparison with diatrizoate. Endoscopy 20(5):244-247, 1988
13. Banerjee A, Grainger S, Thompson R: Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography. BJCP 44(11):445-446, 1990
14. Barkin JS, Casai GL, Reiner DK, Goldberg RI, Phillips RS, Kaplan S: A comparative study of contrast agents for endoscopic retrograde pancreatography. Am J Gastroentrol 86(10):1437-1441, 1991
15. Rodriguez J, Stoltenberg P, Avots A, Nipper M.L, Riggs M, Lasater J, Dyck WP: A prospective randomized comparison of the safety and efficacy of iohexol 180 and diatrizoate 60% as contrast agents for ERCP [abstract]. Gastroenterology 100:297, 1991
16. Hamilton I, Lintott DJ, Rothwell J, Axon AT: Metrizamide as contrast medium in endoscopic retrograde cholangiopancreaticography. Clin Radiol 33(3):293-295, 1982
17. Hannigan BF, Keeling PW, Slavin B, Thompson RP: Hyperamylasemia after ERCP with ionic and non-ionic contrast media. Gastrointest Endosc 31(2):109-110, 1985
18. Jensen AR, Malchow-Moller A, Matzen P, Larsen JE, Moller F, Andersen JR, Magid E: A randomized trial of iohexol versus amidotrizoate in endoscopic retrograde pancreatography. Scand J Gastroenterol 1:83-86, 1985
19. Makela P, Dean PB: The frequency of hyperamylasemia after ERCP with diatrizoate and iohexol. Eur J Radiol 6(4):303-304, 1986
20. Silverman W, Ruffolo T, Rogers D, Hawes R: Post ERCP pancreatitis (PEP); frequency with ionic and non-ionic contrast media in high risk patients [abstract]. Am J Gastroenterol 86:192, 1991
21. Sherman S, Hawes RH, Rathgaber SW, Uzer MF, Smith MT, Khusro QE, Silveman WB, Earle DT, Lehman GA: Post-ERCP pancreatilis: randomized, prospective study comparing a low-and high osmolality contrast agent. Gastrointest Endosc 40(4):422-427, 1994
22. Johnson GK, Geenen JE, Bedford RA, Johanson J, Cass O, Sherman S, Hogan WJ, Ryan M, Silverman W, Edmundowicz S: A comparision of nonionic versus ionic contrast media: results of a prospective mullicenter study. Gastrointest Endosc 42(4):312-316, 1995
23. Kruse A, Brock A, Rodenberg J, Nowakowska-Duawa E, Bjartveit K: Iopenol (Imagopaque 250) compared with diatrizoate (Urografin 219) in endoscopic retrograde changio-pancreatography (ERCP): A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase and diagnostic information (VAS). Eur Radiol 7 (Suppl 4):S131-S134, 1997
24. Johnson GK, Geenen JE, Johanson JF, Sherman S, Hogan WJ, Cass O: Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Gastrointest Endosc 46(3):217-222, 1997
25. Martin DF, England RE, Rosch T, Biehl E, Jeschke B, Heldwein D, Klauser A, Klaveness A, Kristoffersen D: Diagnostic quality in endoscopic retrograde cholangiopancreatography: Comparison between iodixanol and iopromide. Endoscopy 32(10):783-787, 2000
26. Goebel C, Hardt P, Doppl W, Temme H, Hackstein N, Klor HU: Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: a randomized trial. Eur Radiol 10:677-680, 2000
27. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, Nicki N: Endoscopic sphincterotomy, complications and their management. An attempt at consensus. Gastrointest Endosc 37:383-393, 1991
28. Cotton PB: Outcomes of endoscopy procedures: struggling towards definitions. Gastrointest Endosc 40(4):514-518, 1994
29. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12, 1996
30. Cotton PB, Brazer SR: Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography [letter]. Am J Gastroenterol 87(5):682, 1992
31. Ioannou G, Doust J, Rockey DC: Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev (1):CD002147, 2001